High Sugar Intake and Development of Skeletal Muscle Insulin Resistance and Inflammation in Mice: A Protective Role for PPAR-δAgonism

High-Fat Diet-Mediated Lipotoxicity and Insulin Resistance Is Related to Impaired Lipase Expression in Mouse Skeletal Muscle

(2013) Pierre-Marie Badin et al.   ENDOCRINOLOGY

Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-δ agonism correlates with impaired NLRP3 inflammasome activation

(2012) Massimo Collino et al.   BIOCHEMICAL PHARMACOLOGY

Mechanisms for Insulin Resistance: Common Threads and Missing Links

(2012) Varman T. Samuel et al.   CELL

Metabolic actions of fibroblast growth factor 21

(2012) Daniel Cuevas-Ramos et al.   CURRENT OPINION IN PEDIATRICS

Telmisartan Improves Insulin Resistance of Skeletal Muscle Through Peroxisome Proliferator-Activated Receptor-  Activation

(2012) L. Li et al.   DIABETES

Targeted Disruption of Inducible Nitric Oxide Synthase Protects Against Aging, S-Nitrosation, and Insulin Resistance in Muscle of Male Mice

(2012) E. R. Ropelle et al.   DIABETES

Knockdown of NYGGF4 increases glucose transport in C2C12 mice skeletal myocytes by activation IRS-1/PI3K/AKT insulin pathway

(2012) Xue-Qi Zeng et al.   JOURNAL OF BIOENERGETICS AND BIOMEMBRANES

Peroxisome Proliferator-activated Receptor β/δ Induces Myogenesis by Modulating Myostatin Activity

(2012) Sabeera Bonala et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-κB

(2012) Min Suk Lee et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Regulation of glucose transport by insulin: traffic control of GLUT4

(2012) Dara Leto et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

The Role of PPARβ/δ in the Management of Metabolic Syndrome and its Associated Cardiovascular Complications

(2012) Elisa Benetti et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

Targeted Loss of GHR Signaling in Mouse Skeletal Muscle Protects Against High-Fat Diet-Induced Metabolic Deterioration

(2011) A. Vijayakumar et al.   DIABETES

Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity

(2011) Fredirick L. Mashili et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

High Fat Diet-Induced Changes in Mouse Muscle Mitochondrial Phospholipids Do Not Impair Mitochondrial Respiration Despite Insulin Resistance

(2011) Joris Hoeks et al.   PLoS One

Correlation Between the Levels of Circulating Adhesion Molecules and Atherosclerosis in Hypertensive Type-2 Diabetic Patients

(2010) Alberto Francisco Rubio-Guerra et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

The Type of Caloric Sweetener Added to Water Influences Weight Gain, Fat Mass, and Reproduction in Growing Sprague-Dawley Female Rats

(2009) Heather R. Light et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 inob/obmice

(2009) Xiaofan Li et al.   FEBS LETTERS

Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man

(2009) Constantinos Christodoulides et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Diabetes of the Liver: The Link Between Nonalcoholic Fatty Liver Disease and HFCS-55

(2009) Kate S. Collison et al.   Obesity

Ablation of AMP-Activated Protein Kinase  2 Activity Exacerbates Insulin Resistance Induced by High-Fat Feeding of Mice

(2008) N. Fujii et al.   DIABETES

FGF21 attenuates lipolysis in human adipocytes - A possible link to improved insulin sensitivity

(2008) Peter Arner et al.   FEBS LETTERS

In Vivo Activation of Peroxisome Proliferator-Activated Receptor-  Protects the Heart from Ischemia/Reperfusion Injury in Zucker Fatty Rats

(2008) T.-L. Yue et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor   and Altered Metabolic States

(2008) E. S. Muise et al.   MOLECULAR PHARMACOLOGY